The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia

Atherosclerosis

Volumn 126, Issue 2, 1996, Pages 243-252

  Joven, Jorge ^a   Espinel, Eugenia ^b   Simó, José M ^a   Vilella, Elisabet ^a   Camps, Jordi ^a   Oliver, Angel ^c  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Hyperlipidemia; Hypoalbuminemia; Lipoproteins; Membranous nephropathy; Nephrotic syndrome; Oncotic pressure; Proteinuria

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; HYPOALBUMINEMIA; LIPID ANALYSIS; MALE; NEPHROTIC SYNDROME; ONCOTIC PRESSURE; PRIORITY JOURNAL; PROTEINURIA; SMOKING;

EID: 0030601736     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05905-9     Document Type: Article

References (26)

1. Joven J, Vilella E Hyperlipidaemia of the nephrotic syndrome, the search for a nephrotic factor. Nephrol Dial Transplant. 10:1995;314.
2. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med. 330:1994;7.
3. Staprans I, Felts JM, Couser WG Glycosaminoglicans and chylomicron metabolism in control and nephrotic rats. Metab Clin Exp. 36:1987;496.
4. Marsh JB, Drabkin DL Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia. Metab Clin Exp. 9:1960;946.
5. Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med. 323:1990;579.
6. Warwick GL, Caslake MJ, Boulton-Jones JM, Dagen M, Packard CJ, Shepherd J Low density lipoprotein metabolism in the nephrotic syndrome. Metabolism. 39:1990;187.
7. Apple GB, Blum CB, Chien S, Kunis CL, Apple AS The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med. 312:1985;1544.
8. Baxter JH, Goodman HC, Havel RJ Serum lipid and lipoprotein alterations in nephrosis. J Clin Invest. 39:1960;455.
9. D'Amico G, Gentile MG, Manna G, Fellin G, Ciceri R, Cofano F, Petrini C, Lavarda F, Perolini S, Porrini M Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet. 339:1992;1131.
10. Keilani T, Schlueter WA, Levin ML, Batlle DC Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med. 118:1993;246.
11. Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Clin Chem. 41:1995;908.
12. Karadi I, Romics L, Palos G, Doman J, Kaszas I, Hesz A, Kostner GM Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem. 35:1989;2121.
13. Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med. 119:1993;263.
14. Joven J, Vilella E, Costa B, Turner P, Richart C, Masana L Concentrations of lipids and apolipoproteins in patients with well-controlled insulin-dependent and non-insulin dependent diabetes. Clin Chem. 35:1989;813.
15. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmer HG, Seitz C Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 80:1987;458.
16. Simó J, Bertran N, Juanpere M, Camps J, Joven J Evaluación preliminar del analizador automático Monarch 2000. Quim Clin. 8:1989;329.
17. Stierle HE, Oser B, Boesken WH Improved classification of proteinuria by semiautomated ultrathin SDS polyacrylamid gel electrophoresis. Clin Nephrol. 33:1990;168.
18. Warnick GR, Mayfield C, Albers JJ, Hazzard WR Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type III. Clin Chem. 25:1979;279.
19. Cameron JS. A history of the nephrotic syndrome. In: Cameron JS and Glassock RJ. (eds). Nephrotic Syndrome. New York: Dekker, 1987;3-45.
20. Ohta T, Matsuda I Lipid and apoprotein levels in patients with nephrotic syndrome. Clin Chim Acta. 117:1981;133.
21. Baxter JH, Goodman HC, Allen JC Effect of infusion of serum albumin on serum lipids and lipoproteins in nephrosis. J Clin Invest. 40:1961;490.
22. Davies RW, Staprans I, Hutchinson FN, Kaysen GA Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest. 86:1990;600.
23. Cameron JS The nephrotic syndrome and its complications. Am J Kidney Dis. 10:1987;157.
24. Scanu AM Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. J Lab Clin Med. 116:1990;142.
25. Makino K, Scanu AM Lipoprotein(a): nonhuman primate models. Lipids. 26:1991;679.
26. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis. 62:1986;249.